Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

101 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Biomarkers of platelet activation and cardiovascular risk in the DAPT trial.
Berg DD, Yeh RW, Mauri L, Morrow DA, Kereiakes DJ, Cutlip DE, Gao Q, Jarolim P, Michelson AD, Frelinger AL 3rd, Cange AL, Sabatine MS, O'Donoghue ML. Berg DD, et al. Among authors: frelinger al 3rd. J Thromb Thrombolysis. 2020 Jul 18. doi: 10.1007/s11239-020-02221-5. Online ahead of print. J Thromb Thrombolysis. 2020. PMID: 32683645
An exploratory, randomised, placebo-controlled, 14 day trial of the soluble guanylate cyclase stimulator praliciguat in participants with type 2 diabetes and hypertension.
Hanrahan JP, Seferovic JP, Wakefield JD, Wilson PJ, Chickering JG, Jung J, Carlson KE, Zimmer DP, Frelinger AL 3rd, Michelson AD, Morrow L, Hall M, Currie MG, Milne GT, Profy AT. Hanrahan JP, et al. Among authors: frelinger al 3rd. Diabetologia. 2020 Apr;63(4):733-743. doi: 10.1007/s00125-019-05062-x. Epub 2019 Dec 19. Diabetologia. 2020. PMID: 31858186 Free PMC article.
Validation of the ISTH/SSC bleeding assessment tool for inherited platelet disorders: A communication from the Platelet Physiology SSC.
Gresele P, Orsini S, Noris P, Falcinelli E, Alessi MC, Bury L, Borhany M, Santoro C, Glembotsky AC, Cid AR, Tosetto A, De Candia E, Fontana P, Guglielmini G, Pecci A; BAT-VAL study investigators. Gresele P, et al. J Thromb Haemost. 2020 Mar;18(3):732-739. doi: 10.1111/jth.14683. Epub 2019 Dec 16. J Thromb Haemost. 2020. PMID: 31750621
Platelet surface marker analysis by mass cytometry.
Blair TA, Frelinger AL 3rd. Blair TA, et al. Among authors: frelinger al 3rd. Platelets. 2020 Jul 3;31(5):633-640. doi: 10.1080/09537104.2019.1668549. Epub 2019 Sep 22. Platelets. 2020. PMID: 31544564
Using extracellular calcium concentration and electric pulse conditions to tune platelet-rich plasma growth factor release and clotting.
Garner AL, Frelinger AL 3rd, Gerrits AJ, Gremmel T, Forde EE, Carmichael SL, Michelson AD, Neculaes VB. Garner AL, et al. Among authors: frelinger al 3rd. Med Hypotheses. 2019 Apr;125:100-105. doi: 10.1016/j.mehy.2019.02.036. Epub 2019 Feb 16. Med Hypotheses. 2019. PMID: 30902134
Publisher Correction: GLS-409, an Antagonist of Both P2Y1 and P2Y12, Potently Inhibits Canine Coronary Artery Thrombosis and Reversibly Inhibits Human Platelet Activation.
Smolensky Koganov E, Michelson AD, Yanachkov IB, Yanachkova MI, Wright GE, Przyklenk K, Frelinger AL 3rd. Smolensky Koganov E, et al. Among authors: frelinger al 3rd. Sci Rep. 2018 Nov 29;8(1):17580. doi: 10.1038/s41598-018-35956-6. Sci Rep. 2018. PMID: 30498241 Free PMC article.
Laboratory monitoring of P2Y12 inhibitors: communication from the SSC of the ISTH.
Frelinger AL 3rd, Gachet C, Mumford AD, Noris P, Mezzano D, Harrison P, Gresele P; Subcommittee on Platelet Physiology. Frelinger AL 3rd, et al. J Thromb Haemost. 2018 Nov;16(11):2341-2346. doi: 10.1111/jth.14282. Epub 2018 Oct 3. J Thromb Haemost. 2018. PMID: 30284374 No abstract available.
GLS-409, an Antagonist of Both P2Y1 and P2Y12, Potently Inhibits Canine Coronary Artery Thrombosis and Reversibly Inhibits Human Platelet Activation.
Smolensky Koganov E, Michelson AD, Yanachkov IB, Yanachkova MI, Wright GE, Przyklenk K, Frelinger AL 3rd. Smolensky Koganov E, et al. Among authors: frelinger al 3rd. Sci Rep. 2018 Sep 28;8(1):14529. doi: 10.1038/s41598-018-32797-1. Sci Rep. 2018. PMID: 30266987 Free PMC article.
Avatrombopag increases platelet count but not platelet activation in patients with thrombocytopenia resulting from liver disease.
Michelson AD, Smolensky Koganov E, Forde EE, Carmichael SL, Frelinger AL 3rd. Michelson AD, et al. Among authors: frelinger al 3rd. J Thromb Haemost. 2018 Dec;16(12):2515-2519. doi: 10.1111/jth.14295. Epub 2018 Oct 15. J Thromb Haemost. 2018. PMID: 30264918 Clinical Trial.
Tunable activation of therapeutic platelet-rich plasma by pulse electric field: Differential effects on clot formation, growth factor release, and platelet morphology.
Frelinger AL 3rd, Gerrits AJ, Neculaes VB, Gremmel T, Torres AS, Caiafa A, Carmichael SL, Michelson AD. Frelinger AL 3rd, et al. PLoS One. 2018 Sep 26;13(9):e0203557. doi: 10.1371/journal.pone.0203557. eCollection 2018. PLoS One. 2018. PMID: 30256831 Free PMC article.
101 results
Jump to page
Feedback